-
Product Insights
NewThyroid Hormone Receptor Alpha – Drugs In Development, 2024
The Thyroid Hormone Receptor Alpha pipeline drugs market research report outlays comprehensive information on the Thyroid Hormone Receptor Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Hormonal Disorders, Cardiovascular, Metabolic Disorders, and Central Nervous System which include indications of Hypothyroidism, Hypertension, Atherosclerosis, Diabetes, Dyslipidemia, and Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency). It also reviews key players involved...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency)Drug Details:Tiratricol is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Diiodothyropropionic Acid in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Diiodothyropropionic Acid in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Diiodothyropropionic Acid in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency)Drug Details:Di-iodothyropropionic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LNS-8801 in Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. LNS-8801 in Colorectal Cancer Drug Details: LNS-8801 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPN-2853 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPN-2853 in Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPN-2853 in Ovarian Cancer Drug Details: PLX-2853 is under development for the...
-
Product Insights
Allan RE – Steeple View Redevelopment – Pennsylvania
Equip yourself with the essential tools needed to make informed and profitable decisions with our Allan RE - Steeple View Redevelopment - Pennsylvania report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Chap Homes/ Malcolm Allan – Portstown Residential Community – Aberdeenshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our Chap Homes/ Malcolm Allan - Portstown Residential Community - Aberdeenshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Barratt Dev/ Kirkwood Homes/ Malcolm Allan – Kintore East Residential Community – Aberdeenshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our Barratt Dev/ Kirkwood Homes/ Malcolm Allan - Kintore East Residential Community - Aberdeenshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Company Profile
Royal Gold Inc – Company Profile
Royal Gold Inc (Royal Gold) is a mining company, that acquires and manages precious metals royalties, metal streams and similar interests. The company owns royalty interests in producing properties, development stage properties and exploration stage properties. It also offers financing services for the development and exploration of mines. Royal Gold’s other producing properties include Allan, Bald Mountain, Canadian Malartic, Dolores, El Limon and Don Nicolas. Its development properties are Back River, Bateman Gold, Don Mario, Granite Creek and others. The...
Add to Basket